| |
| |
|
| Insider
Information: |
Barabe Timothy C |
| Relationship: |
Director |
| City: |
Woburn |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
663,514 |
|
|
Indirect Shares
|
7,120 |
|
|
| Direct
Value |
$1,591,147 |
|
|
|
Indirect Value
|
$142,400 |
|
|
| Total
Shares |
670,634 |
|
|
| Total
Value |
$1,733,547 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
5
|
|
Stock
price went up :
|
3
|
5
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.5
|
5.0
|
| Percentage
Gain/Loss : |
 51.6%
|
100.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arqule Inc |
ARQL |
Director |
2020-01-16 |
0 |
2005-03-04 |
7,120 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Chief Financial Officer |
2010-02-22 |
49,570 |
2007-06-27 |
0 |
Premium* |
|
|
Affymetrix Inc |
AFFX |
Chief Financial Officer |
2013-03-18 |
166,378 |
|
0 |
Premium* |
|
|
Acer Therapeutics Inc |
ACER |
Director |
2016-11-18 |
12,910 |
2014-03-19 |
0 |
Premium* |
|
|
Veeva Systems Inc |
VEEV |
Director |
2021-06-22 |
6,643 |
2015-12-09 |
0 |
Premium* |
|
|
Selecta Biosciences Inc |
SELB |
Director |
2024-01-02 |
428,013 |
2017-03-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
252 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARQL |
Arqule Inc |
Director |
– • – |
2008-11-17 |
4 |
B |
$2.90 |
$5,919 |
D/D |
2,041 |
21,764 |
2.39 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-01-20 |
4 |
B |
$3.54 |
$1,197 |
D/D |
338 |
22,102 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-02-18 |
4 |
B |
$3.95 |
$4,124 |
D/D |
1,044 |
23,146 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-03-04 |
4 |
B |
$2.90 |
$597 |
D/D |
206 |
23,352 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-03-12 |
4 |
B |
$3.55 |
$1,200 |
D/D |
338 |
23,690 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-04-29 |
4 |
B |
$4.50 |
$599 |
D/D |
133 |
23,823 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-05-14 |
4 |
B |
$3.87 |
$1,200 |
D/D |
310 |
24,133 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-05-18 |
4 |
B |
$4.11 |
$4,122 |
D/D |
1,003 |
25,136 |
2.31 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2009-06-30 |
4 |
B |
$1.80 |
$1,800 |
D/D |
1,000 |
45,274 |
2.66 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-07-24 |
4 |
B |
$5.82 |
$1,199 |
D/D |
206 |
25,342 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-08-05 |
4 |
B |
$5.73 |
$596 |
D/D |
104 |
25,446 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-08-18 |
4 |
B |
$5.26 |
$4,124 |
D/D |
784 |
26,230 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-09-23 |
4 |
A |
$5.01 |
$2,400 |
D/D |
479 |
26,925 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-10-28 |
4 |
A |
$3.44 |
$599 |
D/D |
174 |
27,099 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-11-18 |
4 |
A |
$3.41 |
$4,123 |
D/D |
1,209 |
28,308 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2009-11-20 |
4 |
OE |
$10.11 |
$299,994 |
D/D |
29,673 |
39,674 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-11-23 |
4 |
A |
$3.49 |
$1,794 |
D/D |
514 |
28,822 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2010-01-21 |
4 |
A |
$3.42 |
$1,197 |
D/D |
350 |
29,172 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2010-02-03 |
4 |
OE |
$0.52 |
$66,671 |
D/D |
28,329 |
68,003 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2010-02-03 |
4 |
AS |
$27.92 |
$639,481 |
D/D |
(22,907) |
45,096 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2010-02-10 |
4 |
OE |
$10.11 |
$45,242 |
D/D |
4,475 |
49,571 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2010-02-18 |
4 |
A |
$3.37 |
$4,125 |
D/D |
1,224 |
30,396 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2010-02-22 |
4 |
OE |
$4.92 |
$281,424 |
D/D |
57,200 |
106,771 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2010-02-22 |
4 |
AS |
$30.01 |
$1,716,315 |
D/D |
(57,200) |
49,571 |
0 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2010-02-25 |
4 |
A |
$3.36 |
$598 |
D/D |
178 |
30,574 |
0 |
- |
|
252 Records found
|
|
Page 3 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
